Erratum: Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma [Tumor Biol., DOI: 10.1007/s13277-015-3928-7];Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma

Tumor Biology

Volumn 37, Issue 1, 2016, Pages 1357-1368

  Harada, Yoshikazu ^a,b   Izumi, Hiroto ^c   Noguchi, Hirotsugu ^a   Kuma, Akihiro ^c   Kawatsu, Yuichiro ^c   Kimura, Tomoko ^c   Kitada, Shohei ^a,c   Uramoto, Hidetaka ^c   Wang, Ke Yong ^a   Sasaguri, Yasuyuki ^a,d   Hijioka, Hiroshi ^e   Miyawaki, Akihiko ^b   Oya, Ryoichi ^b   Nakayama, Toshiyuki ^a   Kohno, Kimitoshi ^f   Yamada, Sohsuke ^a,g,h  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b School of Medicine   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d FUKUOKA WAJIRO HOSPITAL   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f Asahi Matsumoto Hospital Sumoto   (Japan)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF GRAZ   (Austria)

Author keywords

Disease free survival (DFS); Early stage OSCC (ESOSCC); Oral squamous cell carcinoma (OSCC); Polypeptide N acetylgalactosaminyltransferase 3 (GalNAc T3); Vessel invasion

Indexed keywords

N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 3; UNCLASSIFIED DRUG; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; COS 1 CELL LINE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; MUCOSA; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; VERY ELDERLY; WESTERN BLOTTING; CYTOPLASM; DISEASE COURSE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOSYLATION; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOPLASM; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOUTH NEOPLASMS; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; YOUNG ADULT;

EID: 84939864723     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4211-7     Document Type: Erratum

References (38)

1. Sasahira T, Kirita T, Kuniyasu H. Update of molecular pathobiology in oral cancer: a review. Int J Clin Oncol. 2014;19(3):431–6.
2. Jermal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
3. Tong XJ, Shan ZF, Tang ZG, et al. The impact of clinical prognostic factors on the survival of patients with oral squamous cell carcinoma. J Oral Maxillofac Surg. 2014;72(12):2497–e1–10.
4. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4–5):301–8.
5. González-García R, Naval-Gías L, Román-Romero L, et al. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck. 2009;31(9):1168–80.
6. Yanamoto S, Yamada S, Takahashi H, et al. Predictors of locoregional recurrence in T1-2N0 tongue cancer patients. Pathol Oncol Res. 2013;19(4):795–803.
7. Capote A, Escorial V, Muñoz-Guerra MF, et al. Elective neck dissection in early-stage oral squamous cell carcinoma—does it influence recurrence and survival? Head Neck. 2007;29(1):3–11.
8. Huang TY, Hsu LP, Wen YH, et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol. 2010;46(1):49–55.
9. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1999;1473(1):67–95.
10. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4(1):45–60.
11. Kitada S, Yamada S, Kuma A, et al. Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. Br J Cancer. 2013;109(2):472–81.
12. Schwientek T, Bennett EP, Flores C, et al. Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans and mammals. J Biol Chem. 2002;277(25):22623–38.
13. Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology. 2003;13(1):1R–16R.
14. Bennett EP, Mandel U, Clausen H. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22(6):736–56.
15. Shibao K, Izumi H, Nakayama Y, et al. Expressions of UDP-N-Acetyl-α-D-galactosaminepolypeptide GalNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer. 2002;94(7):1939–46.
16. Dosaka-Akita H, Kinoshita I, Yamazaki K, et al. N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers. Br J Cancer. 2002;87(7):751–5.
17. Gu C, Oyama T, Osaki T, et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer. 2004;90(2):436–42.
18. Ishikawa M, Kitayama J, Nariko H, et al. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma. J Surg Oncol. 2004;86(1):28–33.
19. Miyahara N, Shoda J, Kawamoto T, et al. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res. 2004;10(6):2090–9.
20. Yamamoto S, Nakamori S, Tsujie M, et al. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas. Pathobiology. 2004;71(1):12–8.
21. Li Z, Yamada S, Inenaga S, et al. Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival. Br J Cancer. 2011;104(12):1882–9.
22. Landers KA, Burger MJ, Tebay MA, et al. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer. 2005;114(6):950–6.
23. Inoue T, Eguchi T, Oda Y, et al. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections—special reference to its association with lymph node metastases. Mod Pathol. 2007;20(2):267–76.
24. Wang ZQ, Bachvarova M, Morin C, et al. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation. Oncotarget. 2014;5(2):544–60.
25. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edition. Wiley-Blackwell 2009
26. Yamamoto E, Kohama G, Sunakawa H, et al. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 1983;51(12):2175–80.
27. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
28. Kimura T, Kitada S, Uramoto H, et al. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma. Histol Histopathol. 2015;30(2):193–204.
29. Nomoto M, Izumi H, Ise T, et al. Structural basis for the regulation of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res. 1999;59(24):6214–22.
30. Ishida T, Hijioka H, Kume K, et al. Notch signaling induces EMT in OSCC cell lines in a hypoxic environment. Oncol Lett. 2013;6(5):1201–6.
31. Uramoto H, Izumi H, Ise T, Tada M, et al. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem. 2002;277(35):31694–702.
32. Izumi H, Yasuniwa Y, Akiyama M, et al. Forced expression of ZNF143 restrains cancer cell. Cancers. 2011;3(4):3909–20.
33. Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging. 1989;29(3):307–35.
34. Kawatsu Y, Kitada S, Uramoto H, et al. The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma. Br J Cancer. 2014;110(10):2583–92.
35. Takeda T, Izumi H, Kitada S, et al. The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma. Tumour Biol. 2014;35(10):10555–69.
36. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.
37. Hagen FK, Van Wuyckhuyse B, Tabak LA. Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl-galactosaminyltransferase. J Biol Chem. 1993;268(25):18960–5.
38. O'Connell BC, Hagen FK, Tabak LA. The influence of flanking sequence on the O-glycosylation of threonine in vitro. J Biol Chem. 1992;267(35):25010–8.